All In Biotech

Drug Trial Radar · NCT02402530

Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I

A Randomized, Double-blind Trial Investigating the Efficacy and Safety of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)

Last checked: Nov 19, 2026Latest source record: May 9, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 459 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

459

Actual

Start

Apr 2015

Primary completion

Aug 2016

Study completion Nov 2016

Sponsor

Lead sponsor
Grünenthal GmbHIndustry
Sponsor type
Industry
First posted
Mar 30, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This clinical trial is being conducted to demonstrate the efficacy of neridronic acid in the treatment of pain associated with complex regional pain syndrome type I (CRPS-I). The trial is divided into 3 periods: a 60-day enrollment period, a 12-week trial period, and an extended follow-up period with visits at Month 6, Month 9, and Month 12. The extended follow-up period will be terminated for all participants after the last participant enrolled completes their Month 6 visit (Visit 9). The double-blind will be maintained throughout the 12-week trial period and extended follow-up period.

Conditions

  • Complex Regional Pain Syndrome, Type I

Interventions

  • PlaceboDrug

    Matching placebo administered as intravenous infusion.

  • Neridronic acid 62.5 mgDrug

    Neridronic acid administered as intravenous infusion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in the Pain Intensity Score to Week 12.Time frame: Baseline; Week 12

Locations

59 sites in 3 countries. Site status is shown where the registry gives one.

  • Site US119 - G & L Research

    Foley, Alabama

  • Site US117 - Valley Pain Consultants

    Scottsdale, Arizona

  • Site US116 - Arizona Pain Specialists

    Scottsdale, Arizona

  • Site US124 - Quality of Life Medical and Research Centers LLC

    Tucson, Arizona

  • Site US154 - Woodland International Research Group

    Little Rock, Arkansas

  • Site US110 - Orange County Research Institute

    Anaheim, California

  • Site US172 - Core Healthcare Group

    Cerritos, California

  • Site US108 - Catalina Research Institute

    Chino, California

  • Site US175 - Inland Pain Medicine

    Colton, California

  • Site US152 - UC San Diego Healthcare Systems, Center for Pain Medicine

    La Jolla, California

  • Site US102 - Samaritan Center for Medical Research

    Los Gatos, California

  • Site US126 - Northern California Research

    Sacramento, California

  • Site US106 - Mountain View Clinical Research

    Denver, Colorado

  • Site US153 - Clinical Research of West Florida Inc - Clearwater

    Clearwater, Florida

  • Site US162 - South Lake Pain Institute

    Clermont, Florida

  • Site US143 - Florida Pain Institute

    Merritt Island, Florida

  • Site US111 - Sunrise Research Institute

    Miami, Florida

  • Site US122 - Precision Research Organization, LLC

    Miami Lakes, Florida

  • Site US104 - Discovery Clinical Trials

    Orlando, Florida

  • Site US133 - Gold Coast Research LLC

    Plantation, Florida

  • Site US171 - Florida Medical Pain Management

    St. Petersburg, Florida

  • Site US121 - Clinical Research of West Florida

    Tampa, Florida

  • Site US165 - Palm Beach Research

    West Palm Beach, Florida

  • Site US131 - Better Health Clinical Research, Inc

    Newnan, Georgia

  • Site US103 - Great Lakes Clinical Trials

    Chicago, Illinois

  • Site US129 - International Clinical Research Institute

    Overland Park, Kansas

  • Site US169 - Massachusetts General Hospital

    Boston, Massachusetts

  • Site US127 - Advance Clinical Research, Inc

    St Louis, Missouri

  • Site US105 - Advanced Biomedical Research of America

    Las Vegas, Nevada

  • Site US101 - Princeton Medical Institute

    Princeton, New Jersey

  • Site US151 - Premier Pain Centers

    Shrewsbury, New Jersey

  • Site US156 - University Clinical Research Center

    Somerset, New Jersey

  • Site US166 - Albany Medical College

    Albany, New York

  • Site US145 - University of Rochester

    Rochester, New York

  • Site US137 - Montefiore Medical Center

    The Bronx, New York

  • Site US135 - The Center for Clinical Research

    Winston-Salem, North Carolina

  • Site US157 - North Star Medical Research

    Middleburg Heights, Ohio

  • Site US149 - Founders Research Corporation

    Philadelphia, Pennsylvania

  • Site US114 - Abington Neurological Associates

    Willow Grove, Pennsylvania

  • Site US112 - Clinical Trials of South Carolina

    Charleston, South Carolina

Showing 40 of 59 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.